ctp

CTP, a cardiac targeting peptide, efficiently and specifically transduces cardiomyocytes in vitro and heart tissue in mouse models. It has potential for the targeted delivery of therapeutic peptides, proteins, and nucleic acids to the heart [1].

CTP-NBD is a cell-permeable, specific inhibitor of the NFκB peptide, which has been utilized in studies of colitis [1] [2].

HYNIC-CTP is a conjugate of HYNIC and CTP (cardiac-targeting peptide). It acts as a chelator, allowing HYNIC to bind with the radioisotope 99mTc, resulting in the formation of 99mTc-HYNIC-CTP. This compound is specifically absorbed by the heart, facilitating cardiac imaging and thereby aiding in the research of heart diseases.

β-Endorphin (β-EP) is an endogenous opioid neuropeptide with diverse biological activities. It is produced via piomelanocortin cleavage in the pituitary gland, hypothalamus, and in lymphocytes, then migrates to its sites of action which include plasma, gut, skin, placenta, cerebrospinal fluid, and cardiac tissues. β-EP induces concentration-dependent decreases in electrically stimulated contraction of the mouse vas deferens that can be reversed by the μ-opioid antagonist CTP and δ-opioid antagonist ICI 174,864. In vivo, β-EP (5 μg, i.c.v.) slows gastrointestinal transit in mice. β-EP (0.5 or 5 μg, i.c.v.) stimulates food intake in rats for 4 to 6 hours, however, this effect is not prolonged with continuous infusion. It antagonizes the appetite-suppressive effects of α-melanocyte-stimulating hormone (α-MSH) for the first three days post administration. β-EP also reduces paralytic demyelination induced by the murine coronavirus MHV-JHM in immunocompetent, but not irradiated or immune-incompetent, mice and rats.